Cite

HARVARD Citation

    Morisco, F. et al. (2018). Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3. United European Gastroenterology journal. 6 (2), pp. 225-237. [Online]. 
  
Back to record